VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 149 filers reported holding VENTYX BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,468,025 | +21.8% | 1,107,631 | +15.0% | 0.50% | +25.3% |
| Q2 2023 | $31,592,829 | +0.7% | 963,196 | +2.9% | 0.40% | -9.3% |
| Q1 2023 | $31,360,054 | -5.5% | 936,121 | -7.5% | 0.44% | -11.1% |
| Q4 2022 | $33,193,973 | -5.8% | 1,012,320 | +0.3% | 0.50% | -7.1% |
| Q3 2022 | $35,228,000 | +352.9% | 1,009,103 | +58.7% | 0.53% | +323.0% |
| Q2 2022 | $7,778,000 | -10.5% | 635,992 | -0.7% | 0.13% | +17.8% |
| Q1 2022 | $8,688,000 | -33.0% | 640,203 | -1.9% | 0.11% | -18.9% |
| Q4 2021 | $12,959,000 | – | 652,509 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 2,298,833 | $77,010,906 | 42.68% |
| Qiming U.S. Ventures Management, LLC | 746,370 | $25,003,395 | 30.26% |
| TCG Crossover Management, LLC | 815,724 | $27,326,754 | 5.33% |
| ACUTA CAPITAL PARTNERS, LLC | 208,500 | $6,984,750 | 5.15% |
| Affinity Asset Advisors, LLC | 260,008 | $8,710,268 | 2.88% |
| Avidity Partners Management LP | 1,917,800 | $64,246,300 | 2.13% |
| Integral Health Asset Management, LLC | 290,000 | $9,715,000 | 1.96% |
| Tri Locum Partners LP | 152,842 | $5,120,207 | 1.56% |
| Vivo Capital, LLC | 602,075 | $20,169,513 | 1.40% |
| Boxer Capital, LLC | 850,000 | $28,475 | 1.40% |